Patriot Scientific der Highflyer 2006
Aber Du bist halt ein Abenteurer. Wenn man mehr Spaß an Abenteuern als am Geld verdienen hat, ist Deine Strategie zu 100% richtig. Und wenn Du nach den Zahlen mal 20% Gewinn machst, kannst Du Dich ja auch mal freuen (nach all den Verlusten in den Monaten zuvor). Unsereins hat mit seiner Strategie des Tradens den Einsatz jedenfalls bereits ver-x-facht (wobei x für einen hohen zweistelligen Bereich steht).
Gleichwohl gönne ich allen Longies gute Zahlen!!!
Posted by: Albie on April 01, 2008 06:00PM
Receipt of Orig or Corrected Ex Parte Reexam Request
Application Type: Re-Examination Status Date: 04-01-2008
From Agora
Hast Du ein solches Bestätigungsdefizit oder ist das einfach Deine Persönlichkeit?
Bist schon ein toller! Wenn ich mal groß bin, dann will ich auch so sein wie Du - janz ohne jedes Abenteuer...
Aber was solls....wenn ich Millionär wäre, weil ich ständig weiss, wann ich kaufen und verkaufen muss, hätte ich besseres zu tun...ich wüsste schon was....
mach ich im juni wieder...
2 wochen in florida angeln ...... jippi.......und bestimmt nicht hier dum rumblubbern ...
der kann sich ja bei uri geller bewerben....
Gehe übrigens trotz der Gewinne noch arbeiten. Wenn auch nur noch spaßeshalber (Freiberufler). Man kann ja nicht das ganze Jahr über Urlaub machen.
Gleichwohl möchte ich es nicht versäumen, auf diesem Wege noch einmal allen PTSC-Lemmingen zu danken, aufgrund derer den Tradern die Gewinne überhaupt erst ermöglicht worden sind. Siehst Du, zu so einem Dank gegenüber den Lemmingen haben sich die Großaktionäre L&S gegenüber den Lemmingen trotz ihrer ernormen Gewinne noch nicht herabgelassen.
So ein Posting ist an Lächerlichkeit wirklich kaum zu überbieten. Ich habe mir fast vor Lachen in die Hose gemacht. Naja, werde ich nächste Woche nach den Zahlen ohnehin...
Der Held der Trader ...
Die Kleine Leuchte ....
Hihi...
Vorschlag ... nimm deine Millionengewinne ... und einfach net mehr posten lass uns Verlierer einfach mit Unseren Träumen und dann is gut ... Kann doch nicht jeder son Carlos Slim wie Du sein ...
CU
@Flirty Ist ja schön dass Du trotz Deine Spielgewinne noch arbeiten gehst, so kannst Du dann auch irgendwann mal wieder bei Null anfangen - dann wenn mal alles verzockt ist.
Bush Administration Speaks Against Patent Overhaul Congress is making progress on the patent reform urged by tech firms, but Bush still opposes it,
Part 1 of a special five-part series. ý
Grant Gross, IDG News Service
Saturday, April 05, 2008 10:00 AM PDT
U.S. Senate negotiators are getting closer to hammering out disagreements that are holding up a patent system overhaul, but President George Bush's administration still has concerns about the bill, an administration official said Friday.
Congressional negotiators have worked out a compromise on applicant quality submissions, called AQS for short, putting more responsibility on patent filers to search for prior art, said Jon Dudas, under secretary for intellectual property in the U.S. Department of Commerce. But the Bush administration is still opposed to the Patent Reform Act's change in the way patent infringement damages would be assessed by courts, he added.
<a href="http://ad.doubleclick.net/jump/pcw_general/printwindow;sz=336x280;abr=!ie4;abr=!ie5;abr=!ie6;ord=012345678?" target="_blank"><img src="http://ad.doubleclick.net/ad/pcw_general/printwindow;sz=336x280;abr=!ie4;abr=!ie5;abr=!ie6;ord=012345678?" width="336" height="280" border="0" alt="">
Currently, courts generally consider the value of the entire product when a small piece of the product infringes a patent. The legislation would allow judges to base damages only on the value of the infringing piece.
Many large tech companies support the change in the way damages would be assessed, saying it's too easy for a patent holder to collect huge damages for a small piece of a product found to be infringing. But opponents of the legislation say it would make it easier for large companies to infringe the patents of small companies or individual inventors.
The Bush administration opposes changes that "limits a court's discretion" in a patent case, but would support changes that help courts more clearly identify factors involved in the infringement, the Department of Commerce said.
"The damages issue is still a very important issue, and one that we want to resolve," Dudas said during a Friday media briefing. "We want to make sure we promote innovation in all business models and in all sectors."
The Coalition for Patent Fairness, whose members include Intel, Amazon.com, Apple, Google and Microsoft, said earlier this week that the patent bill was close to being considered on the Senate floor. The bill is "right on the edge" of Senate consideration, said Mark Isakowitz, a lawyer and lobbyist who runs the coalition.
The coalition has been saying the Senate bill is close to being debated on the Senate floor for weeks now, however. A version of the Patent Reform Act passed in the House of Representatives in September, but has been stalled in the Senate over issues such as the reapportionment of damages.
While the coalition expressed optimism this week, the Biotechnology Industry Association (BIO) said several issues still haven't been ironed out. "A wide range of industries, labor unions and universities continue to have serious concerns about key provisions of the Patent Reform Act," BIO President and CEO Jim Greenwood said in a Tuesday statement.
But Dudas said the applicant quality submissions issue seems to be worked out. The Bush administration supports language now in the bill that would require patent applicants to do a minimum search for old patents covering their inventions, he said. About 55 percent of the U.S. Patent and Trademark Office's (USPTO) resources go into examining patents that are ultimately rejected, he said.
In order for the USPTO to improve the quality of patents granted, "the system must focus on the quality of applications," Secretary of Commerce Carlos Gutierrez said in a letter to senators dated Thursday. "Stated simply, our innovation system can no longer afford the time and the cost of heavily subsidizing poor quality patent applications, which crowd out our most important innovations."
Each applicant applications costs the USPTO US$4,200, while basic filing fees are under $1,000, Dudas added. "It's very easy to apply for something while doing only minimal work," he said.
But a handful of inventors who dialed into the Friday press call with Dudas questioned whether the bill now took the right approach on applicant quality. One man, from Portland, Oregon, said that instead of making more work for small inventors, the USPTO should raise filing fees and increase pay for patent examiners. The European Union has increased its search fees, the inventor said.
"I would expect that's going to reduce the number of filings," the inventor said of raising fees.
http://www.pcworld.com/article/id,144179-pg,1/article.html
Patriot Scientific announced today their Q1 Earnings. The entire release is posted below for your convenience. In addition, keep your eyes out tomorrow for Patriot's Letter to the Shareholders that will be addressing some of your key questions regarding today's earnings and the direction Patriot is heading.
Patriot Scientific reported Q3 FY‘08 pre-tax income of $10.7 million, an increase of 9% over Q3 FY’07. The company’s operating results include $11.7 million in equity earnings from Phoenix Digital Solutions, the joint venture entity owned half by Patriot Scientific and half by The TPL Group. Net income for Q3 FY’08 was $6.3 million, with basic and diluted earnings per share of $0.02. On February 29, Patriot had $25.6 million in current assets, inclusive of $23.2 million in cash and short-term investments. Current liabilities of $4.6 million included $4.0 million in income taxes payable that will be remitted prior to the end of the fourth fiscal quarter.
For the nine months ended February 29, 2008, the company received cash distributions from Phoenix Digital totaling $16.7 million. Phoenix Digital receives its income from licenses purchased by manufacturers who use technologies protected by the MMP™ Portfolio. From these cash flows $5.8 million was invested by Patriot in the repurchase of outstanding shares and warrants, while significant tax liabilities of $9.2 million were paid.
Revenues for Phoenix Digital from technology license agreements for the three and nine-month periods ended February 29, 2008 were $27.9 million and $48.9 million, respectively. Net income for Phoenix Digital increased by 8%, compared to Q3 FY’07, to $25.2 million. As stated in previous company announcements, the dollar amount for each licensing deal varies depending upon factors that include, among other things, the relevance of the patents to each licensee's product revenues and the extent to which the patented technology is incorporated into specific products. Currently more than 40 major electronic companies have signed licenses for the MMP Portfolio.
“Patriot’s strong cash position and public market listing will become the foundation for investing in other businesses,” said recently appointed Patriot Scientific CEO Rick Goerner. “We are aggressively seeking to put the company’s capital to work in the acquisition of new IP technologies and operating businesses that we believe will provide a platform for incremental, sustainable and predictable future growth.”
Goerner confirmed the company’s commitment, and priority, to create increased shareholder value by expanding the business through strategic acquisitions in key technology segments.
“We have been fortunate to benefit from strong past cash flows and it is now time for the company to focus on finding alternative uses for our cash and stock. Many growth companies, and their technologies, could benefit from Patriot’s cash and network resources and its access to the public market. We believe this is a particularly good time to capitalize on these opportunities. The recent addition of Paul Bibeau as Patriot’s vice-president of business development expands our capability to support the evaluation effort of these opportunities. Paul’s background and experience is proving invaluable in allowing us to efficiently sort through and evaluate potential acquisition candidates.”
Goerner added, “I know many current, and prospective, shareholders desire more information about Patriot’s business and future plans. We will provide a supplemental news release with additional details about our business plans and the direction we are moving, as well as answer questions we see commonly posed to us by the investor community.”
About Patriot Scientific
Patriot Scientific is a leading intellectual-property licensing company that develops, markets, and enables innovative technologies that satisfy the demands of fast-growing markets for wireless devices, smart cards, home appliances, network gateways, set-top boxes, entertainment technology, automotive telematics, biomedical devices, industrial controllers and more. Headquartered in Carlsbad, Calif., information about the company can be found at http://www.patriotscientific.com.
An investment profile on Patriot Scientific may be found at http://www.hawkassociates.com/profile/ptsc.cfm. Copies of Patriot Scientific press releases, current price quotes, stock charts and other valuable information for investors may be found at http://www.hawkassociates.com and http://www.americanmicrocaps.com. To receive free e-mail notification of future releases for Patriot Scientific, sign up at http://www.hawkassociates.com/about/alert/.
About the MMP Portfolio
The Moore Microprocessor Patent (MMP) Portfolio contains intellectual property that is jointly owned by the publicly held Patriot Scientific Corporation (OTCBB: PTSC) and privately held The TPL Group. The portfolio includes seven U.S. patents as well as their European and Japanese counterparts. It is becoming widely recognized that these patents protect fundamental technology used in designing microprocessors, microcontrollers, digital signal processors (DSPs), embedded processors and system-on-chip (SoC) devices. The MMP portfolio is exclusively managed by Alliacense, the licensing arm of The TPL Group.
# # #
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Statements in this news release looking forward in time involve risks and uncertainties, including the risks associated with the effect of changing economic conditions, trends in the products markets, variations in the company's cash flow, market acceptance risks, patent litigation, technical development risks, seasonality and other risk factors detailed in the company's Securities and Exchange Commission filings.
Moore Microprocessor Patent (MMP) and Alliacense are trademarks of Technology Properties Limited (TPL). PTSC is a trademark of Patriot Scientific Corporation. All other trademarks belong to their respective owners.
# # #
CONTACTS:
Patriot Scientific Media Relations
John Radewagen
Vice President, Corporate Communications
The Hoffman Agency
408-975-3005
408-219-9199 (mobile)
jradewagen@hoffman.com
Patriot Scientific Investor Relations
Hawk Associates
Ken AuYeung or Frank Hawkins
305-451-1888
patriot.scientific@hawkassociates.com
TPL/Alliacense Media Relations
Shawn Clark, 408-446-4222
Schlüsselfragen werden beantwortet ??
Schaun mer mal ...
Werde mir übrigens jetzt mal wieder ein paar Stücke kaufen. Evtl. lässt der SH den Kurs ja wieder etwas steigen. Und dann wieder raus...
WHAT MAY HAVE HAPPENED
Posted by: rosesny1 on April 09, 2008 08:22PM
I believe that a small portion only of the J3 settlement money may be in the current 10Q. Management said they would include the J3 settlement to the extent that they are required. MY PERSONAL OPINION IS THEY HAVE NOT DONE THIS as I will later explain. I hope some of the lawyers on the board might give us their view, assuming what I am saying here might be correct.
Lambert's figures provide an indication of what may be happening. Lambert's figures, without J3, for a 25% premium come to 25.15 million and his figures based on historical license fees comes to 20.79 million, again without J3. Phoenix actually received 27.92 in Q3.
Now if we suppose that the J3 agreed to pay a large settlement in quarterly installments and if we suppose that the other 14 licensees paid somewhere between Lambert's low of 20.79 million and his 25% premium of 25.15 million, then we are left with the J's paying somewhere between 2.77 million and 7.13 million in the 3rd quarter. If these quarterly payments continue for 8 years, the J3 defendants would pay 88.6 million to 228.16 million. Lambert's number for a J3 settlement with a 50% premium is 106.84 million and for a 100% premium is 142.44 million.
I don't believe there is ANY explanation of the low numbers in the 10Q that jives with what we know except this one. It agrees with Turley's statement that PTSC has "tens of millions" of income per year. It agrees with the Rick Groener Trust buying 100K shares. It agrees with PTSC's decision to make an acquisition. It agrees with the statement, at settlement, that all parties, including TPL and PTSC, are happy.
The one thing, however, that the 10Q does not do, if this explanation is correct, is place the public shareholder on par with members of the BOD or the company. If what I am saying here is correct, then I believe the BOD has gotten bad legal advice. PTSC MUST TELL US IF THERE ARE ONGOING PAYMENTS OR NOT. THEY DO NOT HAVE TO TELL US WHO THEY ARE FROM BUT THEY DO HAVE TO TELL US THAT THEY ARE COMING AND IN WHAT AMOUNTS. THE SEC RULES, I AM SURE, REQUIRE THAT SUCH INFORMATION IS MATERIAL AND MUST BE GIVEN OUT IN SOME GENERAL WAY THAT DOES NOT REVEAL WHO THE INCOME IS FROM. Excuse the shouting but I'm sure many of us feel like shouting now. I believe, as shareholders, we must get together and force management to give us sufficient information to be reasonably informed investors. If there are or are not such payments coming down the line, we have a right to be so informed. All IMHO.
Bei dem Risiko......
Manche sind solche Schlaumeier......
Mit Deiner Weisheit und Deiner Allwissenden Macht solltest Du im Zirkus Roncalli auftreten, dann kannste bestimmt pro Auftritt 10000 verdienen.
Wenn ich hier in den Boards manche Schlaumeier und reiche Millionäre "lese" frage ich mich echt.....wo sind wir hier.
Kauf dir ein "paar" Stück... vermutlich so 10.000.000 um Sie nach der Berechenbarkeit wieder fett abzustoßen.
Zum Glück gilt die Anonymität des Netzes....Jeder ist, was er sein will.....oder mag....
Zuviel Second Life gespielt ...
Thema durch...
Ich hab leider nur 200.000 Stück...entweder ich werd mal reich.....oder Over...
aber damit zu traden ist albern...
Mir scheinen die Zahlen aber eher exclusive des Texas-Vergleiches.
Na mal sehen was die heute schreiben.
Grüße Abeneurer
Was ist passiert: Zahlen die man so nicht erwartet hat, die Zahlungen der J´s sind offensichtlich nicht genannt. Bislang keine Äußerung des BOD, Kurssturz.
Soweit die Fakten.
Schaut man genauer hin, sind die Zahlen (ohne die J´s ) nicht so schlecht.
Zu bemängeln ist allerdings die schlechte PR von PTSC.
Hier hätte, und vielleicht kommt das noch, ein SHL kommen müssen nach dem Motto: so Leute, das ist Fakt, wir haben die und die Summe bekommen und sie ist aus bestimmten Gründen nicht im Filing enthalten. Fakten lägen dann auf dem Tisch und der wahre Kurs von PTSC stände da.
So ist alles nebulös, aber nicht ausgeschlossen ist, dass heute nach Börsenschluss noch der SHL kommt, in dem alles erklärt wird.
Sollte PTSC diese Info-Politik weiter verfolgen, tun sie nicht wirklich was für den Shareholder Value.
Meine Position ist klar: ich bleibe drin und versuche mich noch zu verbilligen, aber wie bei jedem ist die Schmerzgrenze natürlich erreicht.
Jetzt sollte man bei PTSC doch lieber keine Aktionärsversammlung ansetzten - ich glaube dann lyncht man den Vorstand.
Grüße Abenteurer
Kann es sein, dass die J’s tatsächlich im Vergleich zu anderen grossen Firmen nur Peanuts gezahlt haben und das NDA dies verdecken sollte ? Ich denke nicht.
Ich habe mich damit abgefunden, dass Transparenz bei PTSC nicht gegeben ist und wir die Details aus dem Settlement nicht erfahren werden. Ich glaube aber dennoch an eine „business resolution“, die noch viel Geld in die PTSC-Kassen spülen wird. Aber zuerst muss das USPTO die Patente bestätigen, dann wird abgerechnet.
Bis dahin ist alles nur reine Spekulation, leider nagt auch der stetig weiter fallende USD am Wert der PTSC Aktien (alleine der dadurch bedingte Wertverlust ist schon beachtlich für mich).
Optionen
| Boardmail an "Matzelbub" |
Wertpapier: Patriot Scientific |